Publications in collaboration with researchers from Hospital de Cruces (18)

2024

  1. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  2. Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy

    Cancers, Vol. 16, Núm. 16

2022

  1. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level

    Current Urology Reports, Vol. 23, Núm. 6, pp. 93-97

  2. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. Integrated mrna and mirna transcriptomic analyses reveals divergent mechanisms of sunitinib resistance in clear cell renal cell carcinoma (Ccrcc)

    Cancers, Vol. 13, Núm. 17

2020

  1. An integrative omics approach reveals involvement of BRCA1 in hepatic metastatic progression of colorectal cancer

    Cancers, Vol. 12, Núm. 9, pp. 1-24

  2. Identification of recurrent mutations in the microrna‐binding sites of b‐cell lymphoma‐ associated genes in follicular lymphoma

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-12

  3. The urinary transcriptome as a source of biomarkers for prostate cancer

    Cancers, Vol. 12, Núm. 2

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

  2. Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 89-93

  3. Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

    Scientific Reports, Vol. 8, Núm. 1

  4. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms

    Journal of Molecular Diagnostics, Vol. 20, Núm. 1, pp. 34-45

  5. Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy

    Pathology Research and Practice, Vol. 214, Núm. 8, pp. 1110-1114

2017

  1. DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas

    Pathology, Vol. 49, Núm. 7, pp. 731-739

  2. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC) [version 2; referees: 5 approved]

    F1000Research, Vol. 5

2015

  1. Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP

    Experimental and Molecular Pathology, Vol. 99, Núm. 3, pp. 537-545

2014

  1. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes

    Journal of Pathology, Vol. 232, Núm. 1, pp. 32-42